Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Barrett

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
American Journal of Epidemiology|February 1, 1993
Cigarette smoking and the risk of endometrial cancerL A Brinton, R J Barrett, M L Berman, et al.
Cancer|October 15, 1988
Tenckhoff catheter cytology in patients with ovarian cancerK R Geisinger, L W Ng, M B Hopkins, et al.
Obstetrics and Gynecology|August 1, 1989
Primary melanoma of the vagina: a clinicopathologic analysisG C Reid, R W Schmidt, J A Roberts, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channelsR J Barrett, K C Appell, B F Kilpatrick, et al.
Obstetrics and Gynecology|December 1, 1996
Racial differences in endometrial cancer survival: the black/white cancer survival studyH A Hill, J W Eley, L C Harlan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1996
Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group studyM E Randall, R J Barrett, N M Spirtos, et al.
British Journal of Cancer|September 1, 1993
Past and present physical activity and endometrial cancer riskS R Sturgeon, L A Brinton, M L Berman, et al.
Gynecologic Oncology|December 6, 2000
Tubal sterilization and risk of cancer of the endometriumJ V Lacey, L A Brinton, R Mortel, et al.
Epidemiology (Cambridge, Mass.)|November 1, 1993
Moderate alcohol consumption and the risk of endometrial cancerC A Swanson, G D Wilbanks, L B Twiggs, et al.
American Journal of Clinical Oncology|April 1, 1993
Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimenH D Homesley, W F Hahne, B McLees, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
American Journal of Epidemiology|February 1, 1993
Cigarette smoking and the risk of endometrial cancerL A Brinton, R J Barrett, M L Berman, et al.
Cancer|October 15, 1988
Tenckhoff catheter cytology in patients with ovarian cancerK R Geisinger, L W Ng, M B Hopkins, et al.
Obstetrics and Gynecology|August 1, 1989
Primary melanoma of the vagina: a clinicopathologic analysisG C Reid, R W Schmidt, J A Roberts, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channelsR J Barrett, K C Appell, B F Kilpatrick, et al.
Obstetrics and Gynecology|December 1, 1996
Racial differences in endometrial cancer survival: the black/white cancer survival studyH A Hill, J W Eley, L C Harlan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1996
Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group studyM E Randall, R J Barrett, N M Spirtos, et al.
British Journal of Cancer|September 1, 1993
Past and present physical activity and endometrial cancer riskS R Sturgeon, L A Brinton, M L Berman, et al.
Gynecologic Oncology|December 6, 2000
Tubal sterilization and risk of cancer of the endometriumJ V Lacey, L A Brinton, R Mortel, et al.
Epidemiology (Cambridge, Mass.)|November 1, 1993
Moderate alcohol consumption and the risk of endometrial cancerC A Swanson, G D Wilbanks, L B Twiggs, et al.
American Journal of Clinical Oncology|April 1, 1993
Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimenH D Homesley, W F Hahne, B McLees, et al.
Pageof 15